HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

First-line therapy of generalized infantile myofibromatosis with low-dose vinblastine and methotrexate.

AuthorsRaed Azzam, Miguel Abboud, Samar Muwakkit, Nabil Khoury, Raya Saab
JournalPediatric blood & cancer (Pediatr Blood Cancer) Vol. 52 Issue 2 Pg. 308 (Feb 2009) ISSN: 1545-5017 [Electronic] United States
PMID18937326 (Publication Type: Letter)
Chemical References
  • Vinblastine
  • Methotrexate
Topics
  • Disease-Free Survival
  • Humans
  • Infant
  • Male
  • Methotrexate (therapeutic use)
  • Myofibromatosis (drug therapy)
  • Remission Induction
  • Vinblastine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: